Epidermodysplasia verruciformis and human immunodeficiency virus infection: A distinct entity?

Current Opinion in Infectious Diseases

Volumn 25, Issue 2, 2012, Pages 123-125

  Daly, Marie Louise ^a   Hay, Roderick James ^a  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4;

CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EDITORIAL; EPIDERMODYSPLASIA VERRUCIFORMIS; GENERALIZED VERRUCOSIS; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; NONHUMAN; PAPILLOMAVIRUS INFECTION; SKIN BIOPSY; WART VIRUS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; EPIDERMODYSPLASIA VERRUCIFORMIS; HIV-1; HUMANS;

EID: 84857971327     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e3283507fe7     Document Type: Editorial

References (22)

1. Orth G. Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses. Semin Immunol 2006; 18:362-374. (Pubitemid 44511885)
2. Kreuter A, Wieland U. Human papillomavirus-associated diseases in HIV-infected men who have sex with men. Curr Opin Infect Dis 2009; 22:109-114.
3. Akgul B, Kose O, Safali M, et al. A distinct variant of epidermodysplasia verruciformis in a Turkish family lacking EVER1 and EVER2 mutations. J Dermatol Sci 2007; 46:214-216. (Pubitemid 46601835)
4. Rogers HD, Macgregor JL, Nord KM, et al. Acquired epidermodysplasia verruciformis. J Am Acad Dermatol 2009; 60:315-320.
5. Orth G. Human papillomaviruses associated with epidermodysplasia verruciformis in nonmelanoma skin cancers: guilty or innocent? J Invest Dermatol 2005; 125:xii-xiii. (Pubitemid 40981415)
6. Ramoz N, Rueda LA, Bouadjar B, et al. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 2002; 32:579-581. (Pubitemid 35435168)
7. Kurima K, Yang Y, Sorber K, Griffith AJ. Characterization of the transmembrane channel-like (TMC) gene family: functional clues from hearing loss and epidermodysplasia verruciformis. Genomics 2003; 82:300-308. (Pubitemid 36952303)
8. Jablonska S, Orth G. Epidermodysplasia verruciformis. Clin Dermatol 1985; 3:83-96.
9. Majewski S, Skopinska-Rozewska E, Jablonska S, et al. Partial defects of cell-mediated immunity in patients with epidermodysplasia verruciformis. J Am Acad Dermatol 1986; 15:966-973. (Pubitemid 17176809)
10. Pereira de Oliveira WR, Carrasco S, Neto CF, et al. Nonspecific cell-mediated immunity in patients with epidermodysplasia verruciformis. J Dermatol 2003; 30:203-209. (Pubitemid 36417548)
11. Jablonska S, Orth G, Jarzabek-Chorzelska M, et al. Epidermodysplasia verruciformis versus disseminated verrucae planae: is epidermodysplasia verruciformis a generalized infection with wart virus? J Invest Dermatol 1979; 72:114-119. (Pubitemid 10141263)
12. Cooper KD, Androphy EJ, Lowy D, Katz SI. Antigen presentation and T-cell activation in epidermodysplasia verruciformis. J Invest Dermatol 1990; 94:769-776. (Pubitemid 20184376)
13. Yanagi T, Shibaki A, Tsuji-Abe Y, et al. Epidermodysplasia verruciformis and generalized verrucosis: the same disease? Clin Exp Dermatol 2006; 31:390-393.
14. Sri JC, Dubina MI, Kao GF, et al. Generalized verrucosis: a review of the associated diseases, evaluation, and treatments. J Am Acad Dermatol 2011. [Epub ahead of print]
15. Rudlinger R, Smith IW, Bunney MH, Hunter JA. Human papillomavirus infections in a group of renal transplant recipients. Br J Dermatol 1986; 115:681-692. (Pubitemid 17181893)
16. Laffort C, Le Deist F, Favre M, et al. Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common gammac cytokine receptor subunit or JAK-3 deficiency. Lancet 2004; 363:2051-2054. (Pubitemid 38781108)
17. Jacobelli S, Laude H, Carlotti A, et al. Epidermodysplasia verruciformis in human immunodeficiency virus-infected patients: a marker of human papillomavirus- related disorders not affected by antiretroviral therapy. Arch Dermatol 2011; 147:590-596.
18. Morrison C, Eliezri Y, Magro C, Nuovo GJ. The histologic spectrum of epidermodysplasia verruciformis in transplant and AIDS patients. J Cutan Pathol 2002; 29:480-489. (Pubitemid 35034459)
19. Nuovo GJ, Ishag M. The histologic spectrum of epidermodysplasia verruciformis. Am J Surg Pathol 2000; 24:1400-1406.
20. Conrad B, Wu L, Hoxie JA, et al. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci USA 1997; 95:1925-1930. (Pubitemid 27113938)
21. Hernandez PA, Gorlin RJ, Lukens JN, et al. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet 2003; 34:70-74. (Pubitemid 36548793)
22. Van der Burg SH, Palefsky JM. Human immunodeficiency virus and human papilloma virus: why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful. J Transl Med 2009; 7:108.